The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn’s hypothesis in the human melanoma system
Early events responsible of tumor growth in patients with a normal immune system are poorly understood. Here, we discuss, in the context of human melanoma, the Prehn hypothesis according to which a weak antitumor immune response may be required for tumor growth before weakly or non-immunogenic tumo...
Main Authors: | Parmiani, Giorgio, Maccalli, Cristina |
---|---|
Format: | Online |
Language: | English |
Published: |
Landes Bioscience
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489749/ |
Similar Items
-
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
by: Parmiani, Giorgio, et al.
Published: (2015) -
Melanoma Cancer Stem Cells: Markers and Functions
by: Parmiani, Giorgio
Published: (2016) -
Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study
by: Maccalli, Cristina, et al.
Published: (2013) -
Incessant ovulation and ovarian cancer – a hypothesis re-visited
by: Fathalla, M.F.
Published: (2013) -
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy
by: Mazzarella, Tonia, et al.
Published: (2011)